Big pharma faces headwinds in China as vaccine sales decline [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
domestic competition, and shifting consumer behaviours disrupt what was once a booming sector. For years, China has been a major growth driver for premium, privately paid vaccines, with international players such as MSD and GSK capitalising on strong demand from the country's expanding middle class. However, several different events culminated in an abrupt reversal in fortunes last year. GSK's restructuring of its distribution deal for its shingles vaccine Shingrix in December 2024, and MSD's decision to pause sales of its blockbuster human papillomavirus (HPV) vaccine Gardasil until mid-2025, signal mounting pressures. A combination of factors have led to a significant drop in vaccine sales, including China's sweeping anti-corruption cr
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- ??AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trialBusiness Wire
- IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer [Yahoo! Finance]Yahoo! Finance
- IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancerBusiness Wire
- IgniteData Advances Clinical Trial Efficiencies with Successful Deployment at Leading Cancer Center [Yahoo! Finance]Yahoo! Finance
- Is AstraZeneca (AZN) the Best ADR Stock to Buy According to Hedge Funds? [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 3/31/25 - Form 6-K
- 3/31/25 - Form 6-K
- 3/21/25 - Form 6-K
- AZN's page on the SEC website